Page last updated: 2024-11-05

thalidomide and Hyperkalemia

thalidomide has been researched along with Hyperkalemia in 4 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harris, E1
Behrens, J1
Samson, D1
Rahemtulla, A1
Russell, NH1
Byrne, JL1
Fakhouri, F2
Guerraoui, H1
Presne, C1
Peltier, J1
Delarue, R1
Muret, P1
Knebelmann, B2
Izzedine, H1
Launay-Vacher, V1
Deray, G1
Terrier, B1
Joly, D1
Ghez, D1
Hummel, A1

Other Studies

4 other studies available for thalidomide and Hyperkalemia

ArticleYear
Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia.
    British journal of haematology, 2003, Volume: 122, Issue:1

    Topics: Acute Kidney Injury; Aged; Angiogenesis Inhibitors; Female; Humans; Hyperkalemia; Male; Middle Aged;

2003
Thalidomide in patients with multiple myeloma and renal failure.
    British journal of haematology, 2004, Volume: 125, Issue:1

    Topics: Aged; Angiogenesis Inhibitors; Female; Humans; Hyperkalemia; Kidney Failure, Chronic; Male; Middle A

2004
Thalidomide for the nephrologist.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:9

    Topics: Acute Kidney Injury; Angiogenesis Inhibitors; Humans; Hyperkalemia; Thalidomide

2005
Reversible paraparesis in multiple myeloma with renal failure.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:5

    Topics: Acute Kidney Injury; Combined Modality Therapy; Follow-Up Studies; Humans; Hyperkalemia; Kidney Func

2006